Trial
|
Studied treatment |
Control |
Patients |
Size |
Study type
|
Results |
NCT |
Acute coronary syndrome - antithrombotics in all type of patients - antiplatelets drug in ACS (excluding AMI) - antiplatelets drug in all type of patients |
Prandoni, 1991 | aspirin + dipyridamol | placebo | | 88 (44/44) | | | |
CABG surgery - antiplatelets drug in all type of patients |
Pantely, 1979 | aspirin + dipyridamol | control | | 48 (18/30) | | | |
Brussels, 1987 | aspirin + dipyridamol | control | | 49 (24/25) | | | |
Czech, 1986 | aspirin + dipyridamol | control | | 93 (47/46) | | | |
Des Moines, 1980 | aspirin + dipyridamol | control | | 114 (60/54) | | | |
GESIC (aspirin+dipyridamol), 1990 | aspirin + dipyridamol | placebo | | 739 (368/371) | | | |
Brooks, 1985 | aspirin + dipyridamol | placebo | | 320 (160/160) | | | |
Mayo-A, 1984 | aspirin + dipyridamol | placebo | | 407 (202/205) | | | |
Wadsworth, 1985 | aspirin + dipyridamol | placebo | | 198 (96/102) | | | |
Basel, 1989 | aspirin + dipyridamol | placebo | | 125 (62/63) | | | |
Leeds-B, 1985 | aspirin + dipyridamol | placebo | | 125 (61/64) | | | |
Thaulow, 1987 | aspirin + dipyridamol | placebo | | 69 (34/35) | | | |
Toronto dipyridamole, 1987 | dipyridamol | control | | 40 (20/20) | | | |
Ekestrom, 1990 | dipyridamol | placebo | | 360 (174/186) | | | |
Cardiovascular prevention - antiplatelets drug in secondary prevention in patients with CAD - antiplatelets drug in secondary prevention in patients with intermittent claudication |
Hess (2), 1985 | aspirin + dipyridamol | placebo | | 160 (80/80) | | | |
Schoop (2), 1983 | aspirin + dipyridamol | placebo | | 200 (100/100) | | | |
VA study, 1986 | aspirin + dipyridamol | placebo | | 231 (110/121) | | | |
Atlanta (Sbar), 1967 | dipyridamol | control | | 60 (30/30) | Exploratory | | |
Wirecki, 1967 | dipyridamol | control | | 56 (28/28) | Exploratory | | |
Becker, 1967 | dipyridamol | control | | 27 (14/13) | Exploratory | | |
Kinsella, 1962 | dipyridamol | placebo | | 26 (13/13) | Exploratory | | |
Leiberman, 1964 | dipyridamol | placebo | | 38 (19/19) | Exploratory | | |
Zion, 1961 | dipyridamol | placebo | | 28 (14/14) | Exploratory | | |
Dewar, 1961 | dipyridamol | placebo | | 34 (17/17) | Exploratory | | |
Neumann, 1964 | dipyridamol | placebo | | 36 (20/16) | Exploratory | | |
Foulds, 1960 | dipyridamol | placebo | | 48 (24/24) | Exploratory | | |
Igloe, 1970 | dipyridamol | placebo | | 48 (26/22) | Exploratory | | |
PARIS, 1980 | dipyridamol + aspirin | aspirin | | 1620 (810/810) | | | |
PARIS, 1980 | dipyridamol + aspirin | placebo | | 1216 (810/406) | | | |
PARIS-II, 1986 | dipyridamol + aspirin | placebo | | 3128 (1563/1565) | | | |
Coronary artery disease - death and events prevention in all type of patients |
Atlanta (Sbar), 1967 | dipyridamol | control | | 60 (30/30) | Exploratory | | |
Wirecki, 1967 | dipyridamol | control | | 56 (28/28) | Exploratory | | |
Becker, 1967 | dipyridamol | control | | 27 (14/13) | Exploratory | | |
Kinsella, 1962 | dipyridamol | placebo | | 26 (13/13) | Exploratory | | |
Leiberman, 1964 | dipyridamol | placebo | | 38 (19/19) | Exploratory | | |
Zion, 1961 | dipyridamol | placebo | | 28 (14/14) | Exploratory | | |
Dewar, 1961 | dipyridamol | placebo | | 34 (17/17) | Exploratory | | |
Neumann, 1964 | dipyridamol | placebo | | 36 (20/16) | Exploratory | | |
Foulds, 1960 | dipyridamol | placebo | | 48 (24/24) | Exploratory | | |
Igloe, 1970 | dipyridamol | placebo | | 48 (26/22) | Exploratory | | |
PARIS, 1980 | dipyridamol + aspirin | aspirin | | 1620 (810/810) | | | |
PARIS, 1980 | dipyridamol + aspirin | placebo | | 1216 (810/406) | | | |
PARIS-II, 1986 | dipyridamol + aspirin | placebo | | 3128 (1563/1565) | | | |
|
Schwartz (Toronto), 1988 | aspirin + dipyridamol | placebo | | 376 (187/189) | | | |
White (aspirin+dipiridamol), 1991 | aspirin + dipyridamol | placebo | | 499 (245/254) | | | |
Nye (Dunedin), 1990 | aspirin + dipyridamol | placebo | | 72 (35/37) | | | |
Mayo-PTCA, 1989 | aspirin + dipyridamol | placebo | | 207 (102/105) | | | |
|
Hess (2), 1985 | aspirin + dipyridamol | placebo | | 160 (80/80) | | | |
Schoop (2), 1983 | aspirin + dipyridamol | placebo | | 200 (100/100) | | | |
VA study, 1986 | aspirin + dipyridamol | placebo | | 231 (110/121) | | | |
Post myocardial infarction - antiplatelets drug in all type of patient - secondary prevention in all type of patients |
PARIS, 1980 | dipyridamol + aspirin | aspirin | | 1620 (810/810) | | | |
PARIS, 1980 | dipyridamol + aspirin | placebo | | 1216 (810/406) | | | |
PARIS-II, 1986 | dipyridamol + aspirin | placebo | | 3128 (1563/1565) | | | |
Stable angina - antithrombotics in all type of patient |
Atlanta (Sbar), 1967 | dipyridamol | control | | 60 (30/30) | Exploratory | | |
Wirecki, 1967 | dipyridamol | control | | 56 (28/28) | Exploratory | | |
Becker, 1967 | dipyridamol | control | | 27 (14/13) | Exploratory | | |
Kinsella, 1962 | dipyridamol | placebo | | 26 (13/13) | Exploratory | | |
Leiberman, 1964 | dipyridamol | placebo | | 38 (19/19) | Exploratory | | |
Zion, 1961 | dipyridamol | placebo | | 28 (14/14) | Exploratory | | |
Dewar, 1961 | dipyridamol | placebo | | 34 (17/17) | Exploratory | | |
Neumann, 1964 | dipyridamol | placebo | | 36 (20/16) | Exploratory | | |
Foulds, 1960 | dipyridamol | placebo | | 48 (24/24) | Exploratory | | |
Igloe, 1970 | dipyridamol | placebo | | 48 (26/22) | Exploratory | | |
Thrombosis prevention - antithrombotics in general surgery - antiplatelets drug in general surgery - antiplatelets drug in all type of patients - antithrombotics in orthopedic surgery - antiplatelets drug in orthopedic surgery - antiplatelets drug in elective orthopedic surgery - antithrombotics in medical patients - antiplatelets drug in medical patients |
Chicago, 1982 | aspirin + dipyridamol | control | | 27 (12/15) | Exploratory | | |
Morris-B , 1977 | aspirin + dipyridamol | no treatment | | 64 (32/32) | Exploratory | | |
Lyon-I, 1975 | aspirin + dipyridamol | no treatment | | 40 (20/20) | Exploratory | | |
Encke-II , 1976 | aspirin + dipyridamol | placebo | | 59 (34/25) | Exploratory | | |
Hamburg, 1976 | aspirin + dipyridamol | placebo | | 32 (21/11) | Exploratory | | |
Frankfurt, 1981 | aspirin + dipyridamol | placebo | | 39 (25/14) | Exploratory | | |
Morris-A , 1977 | dipyridamol | no treatment | | 48 (24/24) | Exploratory | | |
Parodi I, 1973 | dipyridamol + aspirin | control | | 62 (40/22) | Exploratory | | |
Parodi II, 1973 | dipyridamol + aspirin | control | | 126 (91/35) | Confirmatory - | | |
Australian I, 1975 | dipyridamol + aspirin | control | | 150 (75/75) | Confirmatory - | | |
Australian II, 1976 | dipyridamol + aspirin | control | | 160 (85/75) | Confirmatory - | | |
Toulouse I, 1979 | dipyridamol + aspirin | control | | 104 (38/66) | Confirmatory - | | |
Zekert-III, 1977 | dipyridamol + aspirin | control | | 181 (135/46) | Confirmatory - | | |
Harjola DVT, 1982 | dipyridamol + aspirin | control | | 400 (300/100) | Confirmatory - | | |
Weiss, 1977 | dipyridamol + aspirin | control | | 66 (30/36) | Exploratory | | |
Encke IA, 1976 | dipyridamol + aspirin | placebo | | 30 (21/9) | Exploratory | | |
Encke IB, 1976 | dipyridamol + aspirin | placebo | | 96 (62/34) | Exploratory | | |